Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Quantum Biopharma (QNTM)
NASDAQ:QNTM
Holding QNTM?
Track your performance easily
QNTM Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.50 - $97.50
Previous Close$5.16
Volume18.01K
Average Volume (3M)133.18K
Market Cap
$9.94M
Enterprise Value$6.44M
Total Cash (Recent Filing)$3.51M
Total Debt (Recent Filing)$339.20K
Price to Earnings (P/E)―
Beta0.65
Next Earnings
Mar 27, 2025EPS EstimateN/A
Last Dividend Ex-Date
Nov 27, 2023Dividend YieldN/A
Share Statistics
EPS (TTM)-14.87
Shares Outstanding1,300,480
10 Day Avg. Volume49,771
30 Day Avg. Volume133,175
Standard Deviation5.67
R-Squared0.00106
Alpha0.64
Financial Highlights & Ratios
Price to Book (P/B)0.51
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.50
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Quantum Biopharma News
PremiumCompany Announcements
Quantum Biopharma’s Financial Growth and Stability
Ownership Overview
42.69% Insiders
1.37% Other Institutional Investors
52.15% Public Companies and
Individual Investors
QNTM FAQ
What was Quantum Biopharma’s price range in the past 12 months?
Quantum Biopharma lowest stock price was $3.50 and its highest was $97.50 in the past 12 months.
What is Quantum Biopharma’s market cap?
Currently, no data Available
When is Quantum Biopharma’s upcoming earnings report date?
Quantum Biopharma’s upcoming earnings report date is Mar 27, 2025 which is in 125 days.
How were Quantum Biopharma’s earnings last quarter?
Quantum Biopharma released its earnings results on Nov 13, 2024. The company reported -$4.033 earnings per share for the quarter, missing the consensus estimate of -$2.657 by -$1.377.
Is Quantum Biopharma overvalued?
According to Wall Street analysts Quantum Biopharma’s price is currently Overvalued.
Does Quantum Biopharma pay dividends?
Quantum Biopharma pays a Notavailable dividend of $0.41 which represents an annual dividend yield of N/A. See more information on Quantum Biopharma dividends here
What is Quantum Biopharma’s EPS estimate?
Quantum Biopharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Quantum Biopharma have?
Quantum Biopharma has 1,919,400 shares outstanding.
What happened to Quantum Biopharma’s price movement after its last earnings report?
Quantum Biopharma reported an EPS of -$4.033 in its last earnings report, missing expectations of -$2.657. Following the earnings report the stock price went up 5.8%.
Which hedge fund is a major shareholder of Quantum Biopharma?
Currently, no hedge funds are holding shares in QNTM
---
Quantum Biopharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-93.12%
12-Months-Change
Fundamentals
Return on Equity
-67.43%
Trailing 12-Months
Asset Growth
0.45%
Trailing 12-Months
Company Description
Quantum Biopharma
FSD Pharma, Inc. is a specialty biotech pharmaceutical research and development company. It focuses on developing over time a robust pipeline of FDA-approved synthetic compounds targeting the endocannabinoid system of the human body to treat certain diseases of the central nervous system and autoimmune disorders of the skin, GI tract, and the musculoskeletal system. The company was founded by Thomas Fairfull, Zeeshan Saeed and Anthony J. Durkacz in 1994 and is headquartered in Cobourg, Canada.
---
QNTM Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering QNTM
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-78.80%
reiterated a buy rating 7 months ago
Copying BJ Cook, CFA's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -78.80% per trade.
---